Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

T R D J Radstake, M Svenson, A M Eijsbouts, F H J van den Hoogen, C Enevold, P L C M van Riel, K Bendtzen

Udgivelsesdato: 2009-Nov
OriginalsprogEngelsk
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind68
Udgave nummer11
Sider (fra-til)1739-45
Antal sider6
ISSN0003-4967
DOI
StatusUdgivet - 2008

ID: 20008377